Page last updated: 2024-10-31

mianserin and Hyperlipemia

mianserin has been researched along with Hyperlipemia in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"5% in mean body weight over the course of the study in the mirtazapine group that appeared to reach a plateau at 3 weeks, while no increase was observed in the placebo group."5.10The effects of mirtazapine on plasma lipid profiles in healthy subjects. ( Ekstrom, RD; Esposito, SM; Ford, AL; Golden, RN; Nicholas, LM, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nicholas, LM1
Ford, AL1
Esposito, SM1
Ekstrom, RD1
Golden, RN1

Trials

1 trial available for mianserin and Hyperlipemia

ArticleYear
The effects of mirtazapine on plasma lipid profiles in healthy subjects.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:8

    Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Cholesterol; Coronary Disease; Dose-Response R

2003